• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director

    11/16/23 2:20:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email

    November is Prematurity Awareness Month, Announcement Comes in Celebration of World Prematurity Day on Friday, Nov. 17

    LONG BEACH, Calif., Nov. 16, 2023 /PRNewswire/ -- MemorialCare Miller Children's & Women's Hospital Long Beach, along with Pediatrix Medical Group, who has been a long-standing neonatology partner with MemorialCare, have come together to create the Miller Children's & Women's Neonatal Network. This new relationship enables coordinated delivery of provider services to the neonatal intensive care unit (NICU) network establishing a forum for improved communication, financial transparency, and shared program and provider planning. The Neonatal Network will have shared governance between Miller Children's & Women's and Pediatrix, with the neonatologists remaining employees of Pediatrix.

    Dr. Antoine Soliman, Regional Medical Director of the Miller Children's & Women's Network and Yair Katz, chief executive, Miller Children's & Women's

    Miller Children's & Women's features a level IV NICU, the highest designation in California, signifying it can care for the sickest and smallest babies. In addition, it has an extremely low birth weight program – caring for babies less than 2 pounds at birth – and has a transport program that allows Miller Children's & Women's the ability to support area community hospitals with smaller and lower acuity maternity and neonatal care.  

    "Expanding Miller Children's & Women's Hospital Long Beach as a regional destination for neonatal and pediatric care is an important part of our mission in caring for the most premature and sickest babies, as well as their families," says Yair Katz, chief executive, Miller Children's & Women's. "With all that we are seeing going on in the world today in children's health, we were deeply committed to seeing this through so we can do our part to ensure all babies and their families have access to the highest level of care possible regardless of socioeconomic status."  

    To successfully execute this strategic initiative, Miller Children's & Women's has appointed Dr. Antoine Soliman as the Regional Medical Director of the Miller Children's & Women's Network. In this administrative capacity, Dr. Soliman will oversee the performance and quality of the network, lead the onboarding of new sites and serve on the joint operating committee. Dr. Soliman will remain a practicing neonatologist in a limited capacity in Miller Children's NICU, to maintain his direct patient care provider experience. In addition, Dr. Soliman will continue to serve as medical director of the Miller Children's NICU and oversee the recruitment of his replacement for this role.

    "I'm deeply honored and humbled to accept the regional directorship of the Miller Children's & Women's Neonatal Network," says Dr. Soliman. "Miller Children's & Women's has made great advances in neonatal care the last few years, graduating healthier babies born quite ill and extremely premature. Our team is remarkable and expanding our capabilities further into the community is paramount to us. I can't think of a better time to announce and launch this partnership, as we celebrate Prematurity Awareness Month and World Prematurity Day later this week."

    Miller Children's & Women's, one of eight free standing children's hospitals in California, is unique in that it has a full-service maternity and high-risk program licensed under the children's hospital. This expanded neonatal network will also support regional care by laying the groundwork for recruitment of top talent and bringing access to high-risk maternal and neonatal care into bordering communities' backyards – delivering the highest level of care possible.

    About MemorialCare Miller Children's & Women's Hospital Long Beach:

    MemorialCare Miller Children's & Women's Hospital Long Beach is a member of MemorialCare, a not-for-profit, integrated health care system. Miller Children's & Women's is one of only eight free-standing children's hospitals in California, is recognized by U.S. News & World Report as a 'Best Children's Hospital' for pediatric pulmonology and lung surgery — treating more than 14,000 children each year — and has become a regional pediatric destination for more than 65,000 children, who need specialized care in outpatient specialty and satellite centers. With maternal-fetal medicine specialists and neonatologists available 24/7, Miller Children's & Women's cares for women with high-risk pregnancies and premature infants under one roof.

    About Pediatrix Medical Group

    Pediatrix® Medical Group, Inc. (NYSE:MD) is the nation's leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. The group's high-quality, evidence-based care is bolstered by significant investments in research, education, quality-improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through more than 5,000 affiliated physicians and other clinicians in 37 states. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn, Twitter and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.

     

    MemorialCare Miller Children's & Women's Hospital Long Beach (PRNewsfoto/MemorialCare)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/miller-childrens--womens-announces-new-miller-childrens--womens-neonatal-network-in-partnership-with-pediatrix-medical-group-dr-antoine-soliman-named-regional-medical-director-301991199.html

    SOURCE MemorialCare Miller Children's & Women's Hospital Long Beach

    Get the next $MD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 5, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2026. A detailed press release will be issued the morning of May 5, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. About Pediatrix Medical Group Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children acr

    4/20/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal Medicine

    Maternal-Fetal Medicine Specialists of Tennessee Provides Vital Care for Greater Nashville Area Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced its expansion in Middle Tennessee through a partnership with Tennessee Maternal-Fetal Medicine, further advancing its commitment to delivering high-quality maternal-fetal care. The practice will continue to serve patients at five locations throughout the Greater Nashville area as Maternal-Fetal Medicine Specialists of Tennessee under the Pediatrix Medical Group banner. "We are pleased to welcome Tennessee Maternal-Fetal Medicine to the Pediatrix family," said Mark Ordan, Chief Executive Officer

    3/26/26 4:30:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Welcomes Two Nationally Renowned Physician Leaders

    Dr. James Barry, who will join as Chief Clinical Quality & Transformation Officer, and Dr. Jochen Profit, who will serve as Chief Quality Advisor, bring extraordinary reputations as care quality experts Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is pleased to announce that James Barry, M.D., MBA, will soon join the organization as Chief Clinical Quality & Transformation Officer. Jochen Profit, M.D., MPH, will join Dr. Barry as Chief Quality Advisor. "We are thrilled to welcome two nationally renowned physician leaders to Pediatrix and Obstetrix," said Mark Ordan, Chair of the Board and CEO. "Quality care is at the heart of everything that we do a

    3/24/26 5:10:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    SEC Filings

    View All

    SEC Form DEFA14A filed by Pediatrix Medical Group Inc.

    DEFA14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    4/17/26 4:20:01 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form DEFA14A filed by Pediatrix Medical Group Inc.

    DEFA14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    3/27/26 6:52:03 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form DEF 14A filed by Pediatrix Medical Group Inc.

    DEF 14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    3/27/26 6:50:20 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Pediatrix Medical Group

    Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

    12/16/24 7:46:05 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Jefferies with a new price target

    Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

    9/26/24 7:37:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

    6/7/24 8:14:20 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO and Treasurer Rossi Kasandra H covered exercise/tax liability with 3,676 shares, decreasing direct ownership by 5% to 73,300 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    3/3/26 5:00:10 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    EVP, GC, Chief Admin Off & Sec Moore Mary Ann E was granted 39,925 shares and covered exercise/tax liability with 26,931 shares, increasing direct ownership by 10% to 149,236 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    3/3/26 5:00:12 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Chief Executive Officer Ordan Mark S sold $515,430 worth of shares (23,000 units at $22.41), decreasing direct ownership by 7% to 302,805 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    12/17/25 5:00:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Financials

    Live finance-specific insights

    View All

    Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 5, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2026. A detailed press release will be issued the morning of May 5, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. About Pediatrix Medical Group Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children acr

    4/20/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports Fourth Quarter Results

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.40 per share for the three months ended December 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.50. For the 2025 fourth quarter, Pediatrix reported the following results: Net revenue of $494 million; Net income of $34 million; and Adjusted EBITDA of $66 million. "Our fourth quarter operating results were in line with our revised upward expectations and reflected solid same-unit revenue growth, partially offset by an increase in variable practice incentive compensation," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Ou

    2/19/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Thursday, February 19, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2025. A detailed press release will be issued the morning of February 19, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies

    2/9/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Leadership Updates

    Live Leadership Updates

    View All

    Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its board of directors has appointed Kurt D. Newman, M.D., former President and Chief Executive Officer of Children's National Hospital in Washington, D.C. and Professor Emeritus of Surgery and Pediatrics at George Washington University School of Medicine and Health Sciences, as an independent director, effective July 1, 2025. Dr. Newman, a surgeon and nationally recognized leader in pediatric healthcare and a long-term healthcare executive, served as President and Chief Executive Officer of Children's National Hospital for 12 years, after spending over 25 years there as a pediatric sur

    7/1/25 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

    Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

    1/13/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Board Appoints Sylvia Young as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

    5/4/23 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pediatrix Medical Group Inc.

    SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    11/13/24 4:30:24 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    10/31/24 11:54:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    6/10/24 12:43:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care